Integra LifeSciences Recalls MEDIHONEY Calcium Alginate Dressings Due to Potential Sterility Breach
Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
Integra LifeSciences Corp. is recalling over 55,000 units of MEDIHONEY Calcium Alginate dressings because packaging failures may have compromised the sterile barrier of the products.
What this FDA recall tells you, and what most readers miss
This notice was issued by FDA on April 6, 2026 and geographically references Worldwide. Its severity classification of "medium" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, fda, MedicalDevices.
What Happened
Integra LifeSciences Corp. (NeuroSciences) has initiated a voluntary recall of MEDIHONEY Calcium Alginate dressings. The recall was prompted by potential packaging failures that could lead to a breach in the product's sterile barrier. This issue was identified as a Class II recall by the FDA.
Which Products Are Affected
The recall affects 55,276 units of MEDIHONEY CALCIUM ALGINATE WITH ACTIVE LEPTOSPERMUM HONEY. These dressings are indicated for the management of moderately to heavily exuding wounds. The following models and lot numbers are included:
- Model Number 31012 (UDI-DI: 10381780486909): Lots A24008, A24057, B21123, B24075, C22159, C23177, C24148, D24190, E21365, E24254, E24255, G23393, H21523, H22452, H23443, I22512, I23464, J21693, L22706.
- Model Number 31022 (UDI-DI: 10381780486916): Lots A23045, A23065, A25028, A25056, B23079, B25068, B25077, C21151, C21152, C21155, C21195, C22182, C22196, C23183, C23193, C25152, D23196, D23208, E21300, E22305, E22319, F21407, F21428, F21430, F22333, F24317, G23405, H21544, H22438, H23415, H23442, H23446, H24415, I21610, I21617, J22530, J23551, J23560, J24622, K21723, K21739, K24625, K24646, L21838.
- Model Number 31045 (UDI-DI: 10381780486923): Lots A21056, A22036, A22047, A24036, B21062, B21084, B21100, B21107, B21119, B25110, D21229, D21247, D22251, D22270, D22275, D23236, D23248, D24192, D24220, E21314, E21337, E21361, E22277, E23253, E23271, E24296, F21376, F22361, F22362, F22382, F23369, F23370, G21490, G21504, G22385, G23384, H21506, H21512, H21530, H23450, H23451, I22479, I22481, I22495, I23466, I23498, I24511, I24523, J21680, J21691, K21777, K21801, K21806, K22597, K22609, K22632, K22663, K24650, K24679, L21812, L21823, L22674, L22711, L23649.
Distribution was worldwide, including the U.S. states of TX, MI, FL, IN, MO, CA, VA, NJ, PA, SC, TN, RI, and NY.
What You Should Do
Integra LifeSciences has notified customers through email, fax, letter, press release, telephone, and direct visits. Healthcare providers and consumers should immediately check their inventory for the affected lot numbers. If you possess any of the recalled products, follow the instructions provided in the firm's notification for returns or disposal.
Why This Matters
A breach in the sterile barrier of a medical dressing intended for wound care can lead to contamination, potentially increasing the risk of infection for patients.
Source
FDA (Recall Number: Z-1364-2026)
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →Frequently Asked Questions
Common questions about this FDA recall.